CASP4 and neoplasm: Furthermore, Treg from melanoma, Treg from TC-1 tumor, Treg from breast tumor, Treg from B16 tumor, Treg from MC38 tumor, and Treg from CT26 tumor upregulated 2, 18, 9, 42, 27, and 9 caspase-1 secretomic genes, and 8, 33, 16, 72, 39, and 11 caspase-4 secretomic genes, respectively.